Artificial Intelligence and Counterfactually Actionable Responses to End HIV (AI-CARE-HIV)

人工智能和反事实可行的终结艾滋病毒应对措施 (AI-CARE-HIV)

基本信息

  • 批准号:
    10699171
  • 负责人:
  • 金额:
    $ 73.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-25 至 2027-03-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Florida has the highest incidence of Human Immunodeficiency Virus (HIV) infections in the US, with marked social and racial disparities. About 40% of people with HIV in Florida do not reach undetectable viral load, and Black African Americans are the most affected. Besides well-known sociodemographic factors contributing to unfavorable outcomes and disparities, part of such remains unexplained and cannot be actioned upon. Advances in artificial intelligence (AI) and increasing availability of large real-world data (RWD) databases, e.g., electronic health records (EHRs) and administrative claims data, are ideal for developing models for precision health. However, the full capabilities of AI are still hampered by the fact that EHRs are not well integrated with other relevant data sources, containing information on social and behavioral determinants of health (SDoH), especially important for HIV care access and outcomes. Further, a strong determinant of HIV outcomes is stigma, which is not captured in structured fields of EHRs, but can be identified in clinical notes via natural language processing. In fact, many other contextual- and individual-level SDoH can be extracted from clinical narratives in EHRs. Another critical problem with AI built on RWD is that, due to inherent bias in observational data like EHRs, the AI models might identify wrong effects for interventions. Thus, alternative predictions (i.e., counterfactuals) of naïve AI systems might be mistaken, potentially leading to harm. Causal inference methods are being increasingly coupled with AI to address such bias. The overarching goal of this project is to develop “AI-CARE- HIV,” an actionable counterfactual RWD AI framework to improve HIV outcomes in Florida, in particular reducing disparity through addressing SDoH. We hypothesize that a portion of the unexplained systemic disparity can be elucidated by combining causal inference and AI models that exploit complex interactions between individual- and contextual-level SDoH. This framework can then be used to develop an unbiased (under certain assumptions), actionable model usable for planning and implementing clinical and public health interventions. We will develop the project through the OneFlorida+ Clinical Research Consortium, which collates RWD data from >16.8M Floridians, and specifically the OneFlorida+ HIV cohort (now N=71,363). Our project aims to: (1) Enhance the cohort by incorporating large-scale SDoH (9,000+) and prospectively validate new SDoH, including stigma, using NLP; (2) Create polysocial risk scores from SDoH, identify population-level causal effects of SDOH-conditioned interventions on to HIV outcomes, and develop individualized counterfactual AI models for HIV outcomes, calibrated to reduce disparity; (3) Plan –with healthcare providers, State officials, citizen scientists– targeted clinical and public health interventions anchored on our counterfactual AI models, using implementation science, standardized protocols (e.g., CONSORT-AI). Our team includes multidisciplinary (methodological, clinical, qualitative) expertise supported by OneFlorida+, Fl Dept of Health, and minority- serving entities. We expect impact at multiple levels, from infrastructure enhancement to public health benefit.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jiang Bian其他文献

Jiang Bian的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jiang Bian', 18)}}的其他基金

ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
ACTS(AD 临床试验模拟):为阿尔茨海默病临床试验模拟系统开发先进的信息学方法
  • 批准号:
    10753675
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
Disparities of Alzheimer's disease progression in sexual and gender minorities
性少数群体中阿尔茨海默病进展的差异
  • 批准号:
    10590413
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
Post-Acute Sequelae of SARS-CoV-2 Infection and Subsequent Disease Progression in Individuals with AD/ADRD: Influence of the Social and Environmental Determinants of Health
AD/ADRD 患者 SARS-CoV-2 感染的急性后遗症和随后的疾病进展:健康的社会和环境决定因素的影响
  • 批准号:
    10751275
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
An end-to-end informatics framework to study Multiple Chronic Conditions (MCC)'s impact on Alzheimer's disease using harmonized electronic health records
使用统一的电子健康记录研究多种慢性病 (MCC) 对阿尔茨海默病的影响的端到端信息学框架
  • 批准号:
    10728800
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
AI-ADRD: Accelerating interventions of AD/ADRD via Machine learning methods
AI-ADRD:通过机器学习方法加速 AD/ADRD 干预
  • 批准号:
    10682237
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)
推进不同人群的精准肺癌监测和结果 (PLuS2)
  • 批准号:
    10752848
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
Eligibility criteria design for Alzheimer's trials with real-world data and explainable AI
利用真实数据和可解释的人工智能设计阿尔茨海默病试验的资格标准
  • 批准号:
    10608470
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge
通过对真实世界数据和生物医学知识的综合分析,计算药物再利用用于 AD/ADRD
  • 批准号:
    10576853
  • 财政年份:
    2022
  • 资助金额:
    $ 73.14万
  • 项目类别:
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge
通过对真实世界数据和生物医学知识的综合分析,计算药物再利用用于 AD/ADRD
  • 批准号:
    10392169
  • 财政年份:
    2022
  • 资助金额:
    $ 73.14万
  • 项目类别:
PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases
PANDA-MSD:通过网络分布式算法对多系统疾病进行预测分析
  • 批准号:
    10677539
  • 财政年份:
    2022
  • 资助金额:
    $ 73.14万
  • 项目类别:

相似国自然基金

新致病基因SDK2影响细胞粘附导致先天性白内障的机制研究
  • 批准号:
    82371038
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
蜗牛粘液糖胺聚糖影响中性粒细胞粘附和迁移在治疗急性呼吸窘迫综合征中的作用研究
  • 批准号:
    82360025
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
耦合孔连通性以及物质输运对骨组织工程支架细胞粘附和增殖的影响
  • 批准号:
    12302397
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
液下超疏气电极表面的气泡粘附状态调控及其对气体析出过程的影响机制研究
  • 批准号:
    22372016
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
再生微粉改性沥青-再生粗骨料粘附性及其对混合料性能演化的影响机理
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
粘附蛋白结合与膜脂动态重排之间的相互影响研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
羟基磷灰石表面台阶结构对骨髓间充质干细胞粘附和分化的影响及机制研究
  • 批准号:
    32160226
  • 批准年份:
    2021
  • 资助金额:
    36 万元
  • 项目类别:
    地区科学基金项目
接触起电对固-固电介质干接触界面粘附影响的机理研究
  • 批准号:
    52105179
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
TGM2基因影响MDCK细胞粘附的功能和机制研究
  • 批准号:
    32160164
  • 批准年份:
    2021
  • 资助金额:
    35 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 73.14万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了